Skip to main content
. 2019 Jan 5;11:2. doi: 10.1186/s13195-018-0456-x

Table 2.

Distribution of Erlangen Score neurochemical categories across the four diagnostic groups

Diagnostic category Erlangen Score neurochemical category
Improbable AD Possible AD Probable AD
Control group (n = 66)a 37 (56.1%) 28 (42.4%) 1 (1.5%)
MCI-Stable group (n = 74)a 29 (39.2%) 25 (33.8%) 20 (27.0%)
MCI-AD group (n = 70)b 3 (4.3%) 16 (22.9%) 51 (72.8%)
ADD group (n = 168)b 9 (5.4%) 35 (20.8%) 124 (73.8%)

Presented as number (percentage of the total number) in a given diagnostic group

AD Alzheimer’s disease, ADD Alzheimer’s disease dementia, MCI mild cognitive impairment

aDistribution significantly different (p < 0.005) from distributions in all three other categories

bDistribution significantly different (p < 0.005) from distributions in Control and MCI-Stable group, but not in ADD group (p = 1.0)